PUR001 / Purinomia - LARVOL DELTA

Safety of PUR001 Monotherapy in Patients With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=23 | Recruiting | Sponsor: Purinomia Biotech, Inc. | Not yet recruiting ➔ Recruiting | Trial completion date: Sep 2023 ➔ Dec 2023 | Trial primary completion date: Sep 2023 ➔ Dec 2023

Enrollment open • Metastases • Monotherapy • Trial completion date • Trial primary completion date • Oncology • Solid Tumor